Life Sciences Virtual Investor Forum to Showcase 22 Public Companies Across Biotech, Diagnostics, and Digital Health

B2i Digital, Inc. invites investors to the Life Sciences Virtual Investor Forum, a two-day event on June 24 and 25, 2026, co-hosted by Virtual Investor Conferences and Zacks Small-Cap Research. The forum provides a platform for 22 public companies to present live, followed by real-time Q&A and one-on-one meetings, aiming to streamline investor access to management teams across critical life sciences sectors.

As the Official Marketing Partner, B2i Digital integrates the forum into its ecosystem, leveraging a distribution network of over 1.7 million retail and institutional market participants. The company has a track record of amplifying over 115 investor conferences, driving qualified investors to presentations and subsequent meetings. Zacks Small-Cap Research, a preferred provider in the OTC Markets Group’s Research Marketplace, brings independent research and life sciences analyst support to the event.

The lineup spans clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science, and AI-powered digital health. Companies include Protalix BioTherapeutics, CytoSorbents Corporation, Jaguar Health, Reviva Pharmaceuticals, 4DMedical, Prostatype Genomics, Abingdon Health, Innovotech, IMUNON, Envoy Medical, and Phio Pharmaceuticals, among others.

Each company has a 30-minute slot for a live presentation and Q&A. Investors can request one-on-one meetings via the Axle Access platform. Replays will be available on B2i Digital and OTC Markets YouTube channels.

David Shapiro, CEO of B2i Digital, emphasized the value of pairing direct access to management with independent research. ‘Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter, and pairing that access with independent research from Zacks makes the forum more valuable on both sides,’ he said.

The event is significant for investors seeking exposure to early-stage and growth companies in high-impact fields. The inclusion of Zacks Small-Cap Research as co-host adds credibility, as its analysts provide company-sponsored research distributed across investor channels. The forum also features companies from exchanges including NYSE, Nasdaq, TSX, ASX, and OTC Markets.

Registration and company profiles are available at the Virtual Investor Conferences website. Throughout the year, Virtual Investor Conferences, an OTC Markets Group property, hosts similar events featuring public companies worldwide.

This forum represents a streamlined approach for investors to evaluate multiple companies in a short timeframe, potentially accelerating due diligence. For the presenting companies, it offers visibility among a targeted audience of life sciences investors, supported by B2i Digital’s marketing engine and Zacks’ research credibility.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Life Sciences Virtual Investor Forum to Showcase 22 Public Companies Across Biotech, Diagnostics, and Digital Health.

The post Life Sciences Virtual Investor Forum to Showcase 22 Public Companies Across Biotech, Diagnostics, and Digital Health appeared first on citybuzz.